|Bid||50.09 x 100|
|Ask||51.57 x 100|
|Day's Range||50.62 - 51.00|
|52 Week Range||37.38 - 51.13|
|PE Ratio (TTM)||52.89|
|Dividend & Yield||1.06 (2.09%)|
|1y Target Est||N/A|
Abbott completed the acquisition of St. Jude Medical in January 2017. It contributed significantly to its 2Q17 sales.
In 2Q17, Abbott Laboratories' (ABT) Medical Devices segment reported a strong performance once again, registering a YoY sales growth of 89.2%.
On July 20, 2017, Abbott Laboratories (ABT) released its 2Q17 earnings. That day, ABT stock rose more than 4.0% from its closing price of $49.40 on July 19, 2017.